Understanding the beneficial mechanisms of ethyl pyruvate achieved through the regulation of HMGB1 may contribute to the development of novel biomarkers for monitoring diaphragmatic dysfunction during the use of MV and contribute to the growing knowledge of precise pathogenic mechanisms of combinatorial infection and MV involved in the development of diaphragmatic damage. This evidence concerns the gene HMGB1 and infection.